Nationwide Fund Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-92,891
| Closed | -$3.36M | – | 1329 |
|
|
2017
Q3 | $3.36M | Buy |
92,891
+213
| +0.2% | +$7.71K | 0.01% | 1199 |
|
|
2017
Q2 | $2.4M | Buy |
92,678
+50,025
| +117% | +$1.29M | 0.01% | 1347 |
|
|
2017
Q1 | $819K | Sell |
42,653
-2,938
| -6% | -$56.4K | ﹤0.01% | 1874 |
|
|
2016
Q4 | $760K | Buy |
45,591
+1,376
| +3% | +$22.9K | ﹤0.01% | 1934 |
|
|
2016
Q3 | $910K | Hold |
44,215
| – | – | ﹤0.01% | 1846 |
|
|
2016
Q2 | $1.35M | Sell |
44,215
-802
| -2% | -$24.5K | 0.01% | 1558 |
|
|
2016
Q1 | $1.71M | Sell |
45,017
-555
| -1% | -$21.1K | 0.01% | 1424 |
|
|
2015
Q4 | $1.97M | Buy |
45,572
+896
| +2% | +$38.7K | 0.01% | 1368 |
|
|
2015
Q3 | $1.67M | Sell |
44,676
-162
| -0.4% | -$6.07K | 0.01% | 1468 |
|
|
2015
Q2 | $1.52M | Buy |
+44,838
| New | +$1.52M | 0.01% | 1602 |
|